Vapreotide
Jump to navigation
Jump to search
![]() | |
| Clinical data | |
|---|---|
| Trade names | Sanvar |
| Synonyms | Octastatin |
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 30 minutes |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| PubChem SID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C57H70N12O9S2 |
| Molar mass | 1131.37 g/mol |
| 3D model (JSmol) | |
| Density | 1.4 g/cm3 |
| Boiling point | 1,540.9 °C (2,805.62 °F) |
| |
Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea.[1]
